Elevated secretion of glucocorticoids (GCs) or hypersensitivity to GCs has a permissive effect on development of obesity and leads to abnormalities of body-fat distribution. Recent studies demonstrated GCs act as antagonists of leptin in rodents.
INTRODUCTION
Leptin, a hormone secreted by adipocytes (1) , acts via a long form of the leptin receptor (OBRb) expressed in specific nuclei of the hypothalamus (2) and regulates food intake and energy expenditure (3, 4, 5) . Based on sequence homology, OBR belongs to the class I cytokine receptor family, which includes receptors for interleukin-6 (IL-6), leukocyte inhibitory factor (LIF) and granulocyte colony stimulating factor (G-CSF) (6, 7) . OBRb has a long cytoplasmic domain containing several motifs for signal transduction through the JAK/STAT pathway (8) .
Leptin/OBRb complex formation leads to the induction of tyrosine phosphorylation through its association with JAK2 (8, 9) . The activated JAK2 phosphorylates a distal tyrosine (Y 1138) (10) on the receptor, similar to STATs proteins (8, 9, 10) . Although leptin can activate STAT1, STAT3, STAT5 and STAT6 (11, 12) , it only activates STAT3 in the rodent hypothalamus (13) . Rodents with defective leptin receptors such as db/db mice and Zucker (fa/fa) rats result in morbid obesity and extreme leptin resistance (14, 15) . Although mutations of the human leptin receptor gene have been identified (16) , obesity in humans is rarely due to defective receptors (17) . Most obese humans have elevated serum leptin concentrations that do not induce the expected responses, suggesting reduced sensitivity to leptin (18) . Several studies reported the mechanism for leptin resistance, including such as reduced leptin transport across the blood-brainbarrier and impaired signaling downstream of the leptin receptor (19, 20, 21) .
Orexigenic molecules were reported and some of them antagonized leptin action in vivo (3, 22, 23) . Hypercortisolism resulting from exogenous administration or endogenous overproduction of glucocorticoids (GCs) is known to cause central obesity associated with hyperinsulinemia and also hyperleptinemia (24). GCs-mediated regulation of cytokine production and action has been extensively investigated. GCs inhibit the transcription of most proinflammatory cytokines such as IL-1, IL-2, IL-6, IL-8, IFN-γ and TNF-α (25). In addition to the inhibition of a cytokine expression, GCs can often negatively regulate its subsequent signaling pathway (26, 27, 28). In contrast, GCs stimulate the expression of ob gene and leptin secretion in rodents or humans (29, 30) .
Recent studies demonstrated the ability of GCs to modulate leptin action in vivo.
Adrenalectomy enhances the effects of intracerebroventricular (icv) administration of leptin on food intake and body weight in normal rats (31) . In the same study, the supplementation of adrenalectomized rats with dexamethasone (DEX) inhibited the enhanced leptin action. It was also demonstrated that central DEX injection induces obesity associated with hyperleptinemia in normal rats (32) . These findings suggest that GCs act as counter-regulatory hormones of leptin. However, the molecular basis for the cross-talk between the OBRb and GCs pathway has remained unclear. In the present study, we report the acute effects of DEX on the leptin-induced JAK/STAT pathway in vitro and in vivo. We also further investigated the intracellular signal transduction mechanism of GCs-mediated modulation of leptin signaling.
Huh7 cells were grown in RPMI supplemented with 5% fetal calf serum, 50 U/ml penicillin G and 50 µg/ml streptomycin at 37 °C under 5% CO 2 . The cDNA encoding mouse leptin receptor long form (OBRb) was generated as described previously (9) . For binding assays, Huh7 cells were grown in 24-well plates and transfected using 0.5 µl of LipofectAMINE (Life Technologies, Gaithersburg, MD) and 700 ng of DNA per well according to the manufacturer's protocol. For Western blotting experiments, cells were grown in 6-well plates and transfected using 7 µl of LipofectAMINE and 2 µg of DNA per well. At 48 h post-transfection including 15 h of serum deprivation, cells were incubated for 5 or 15 min with 1 nM leptin. Cells were then washed three times with ice-cold phosphate-buffered saline (PBS), dissolved in lysis buffer, CelLytic-M, and centrifuged at 12,000 rpm at 4 °C for 20 min.
Binding assays:
Huh7 cells expressing OBRb were incubated with 100,000 cpm of 125 I-leptin (New England Nuclear Life Science Products, Boston, MA) in RPMI medium containing 1 mg/ml of bovine serum albumin (Sigma, Saint Louis, MO) at 4 °C for 2 h, in the presence or absence of 100 nM unlabeled mouse recombinant leptin. The cells were then washed 3 times with ice-cold PBS and dissolved in lysis buffer consisting of 1% Nonidet P-40, 0.5% Triton X-100 and 1N NaOH. The radioactivity in the lysates was measured in a gamma counter. Nonspecific binding was determined as the radioactivity bound in the presence of 100 nM unlabelled leptin.
Animals:
Adult male Sprague-Dawley rats obtained from Shizuoka Laboratory Animal Center (Shizuoka, Japan) were housed at 22 °C in a 12-12 h light-dark cycle environment (light on at 7:00, off at 19:00), and provided with standard laboratory diet (Oriental Yeast, Tokyo) and tap water ad libitum. The experimental protocol was approved by the Animal Care and Use Committee at Nagasaki University.
Instrument (Narishige Scientific Instrument Lab., Tokyo, Japan) under pentobarbital anesthesia (40 mg/kg, intraperitoneal administration). A stainless steel wire stylet (29 gauge) was inserted into the guide cannula and was tightly fixed on the skull with dental cement to prevent leakage of the cerebrospinal fluid.
Icv infusion of dexamethasone:
After a seven-day recovery period, the rats were divided into three groups; the control group, the leptin group and the DEX/leptin group. The rats were icv injected with a bolus of vehicle (6.0 µl of PBS with 0.1% of BSA) for the control group, leptin (7.5 µg dissolved in 6.0 µl of vehicle) for the leptin group, and DEX (5.0 µg dissolved in 6.0 µl of vehicle) and leptin (7.5 µg dissolved in 6.0 µl of vehicle) for the DEX/leptin group via the cannula (1.0 µl/min). All treatments were performed as close to 19:00 as possible, when the dark phase began. To measure the food intake of each group, the food was weighed 24 h after the icv administration of DEX, leptin or vehicle.
Tissue excision and preparation:
At 12 h after the injection, leptin (7.5 µg dissolved in 6.0 µl of vehicle) or the same volume of vehicle was administered via the icv cannula (1.0 µl/min) to the leptin group and the DEX/leptin group. At 30 min after the infusion, the rats were decapitated, and the whole hypothalamus was dissected in ice-cold saline on the ice and immediately frozen in liquid nitrogen until the assays. The hypothalamus was homogenized in lysis buffer, CelLytic-MT, and centrifuged at 14,000 rpm at 4 °C for 10 min. The protein concentration of the supernatant was assayed using a BCA Protein
Assay Reagent Kit (Pierce, Rockford, IL).
Western blotting:
In the in vitro study, 40 µl of the cell lysates was mixed with sodium dodecyl 
Statistical analysis:
Differences between two groups were determined by two-tailed Student's ttest. P value < 0.05 was considered to be statistically significant. All values are expressed as means ± SE.
RESULTS

Effects of DEX on STAT3 phosphorylation in vitro:
It is well known that administration of GCs to rodents and humans results in obesity associated with hyperleptinemia in addition to hyperinsulinemia. In this study,
we examined the effects of dexamethasone (DEX) on leptin-induced JAK/STAT signaling pathway using human hepatoma cell lines (Huh7). Due to a lack of endogenous leptin receptor, we transiently transfected OBRb cDNA to Huh7 cells (33) .
Leptin has been shown to activate STAT1, STAT3, STAT5 and STAT6 in other cell lines (8, 12) . We tested which STAT proteins might be involved in leptin signaling in Huh7 OBRb is a member of the class I cytokine receptor superfamily, which includes receptors for interleukin 6 (IL-6), leukemia inhibitory factor (LIF), prolactin (PRL), erythropoietin (EPO) and growth hormone (GH). We performed parallel experiments with Huh7 cells expressing endogenous IL-6 and LIF receptor. DEX showed no effect on IL-6-or LIF-induced STAT3 phosphorylation in either a dose-or time-dependent manner (Fig. 1D, 1E ).
Effects of DEX on JAK2 phosphorylation in vitro:
JAK2 is presumed to be STAT3 tyrosine kinases involved in signaling by the cytokine subfamily to which OBRb belongs. We therefore examined whether DEX (Fig. 1B, 1C) , DEX attenuated the phosphorylation of STAT3 in cells co-expressing JAK2 and OBRb (Fig. 2C) .
Effects of dexamethasone on 125 I-leptin binding:
To test whether DEX decreases the cell surface expression of leptin receptor in Huh7 cells transiently expressing OBRb, we studied the effects of DEX on 125 I-leptin binding to the cells. Cells were incubated with 0-100 nM of DEX for 1 h and then subjected to 125 I -leptin binding assay. DEX pretreatment had no significant effects on the specific binding of 125 I -leptin to the cells expressing OBRb (Fig. 3) .
The effects of icv infusion of DEX on leptin action in vivo:
To test whether DEX antagonizes the inhibitory effect of leptin in vivo, we measured the cumulative food intake 24 h after the infusion in Sprague-Dawley rats.
As expected, a single icv infusion of leptin significantly suppressed food intake compared with the vehicle-infused control rats. Cumulative food intake 24 h after combined icv infusion of leptin and DEX increased three-fold compared with icv leptin infusion alone (Fig. 4A) . Next, we examined the effect of DEX on the leptin signaling in the hypothalamus. Western blotting was carried out using anti-phospho-STAT3
antibody as a primary antibody in the hypothalamus at 30 min after icv infusion of leptin. Pretreatment of icv DEX infusion for 12 h prior to infusion of leptin decreased the leptin-induced STAT3 phosphorylation in the hypothalamus without affecting the total amount of STAT3 protein (Fig. 4B) .
The mechanism of the DEX effects on JAK/STAT signaling pathway:
The mechanism by which DEX inhibited leptin-induced JAK/STAT signaling was further examined. DEX rapidly inhibited the leptin-induced STAT3 phosphorylation, suggesting that these effects did not require de novo protein synthesis.
DEX has been shown to modulate the activity of several protein kinases, including protein kinase C (PKC) (35) and mitogen-activated protein kinase (MAPK) (36) . To determine whether the inhibitory effects of DEX on leptin-induced STAT3 phosphorylation is mediated through these kinases, we investigated the inhibitory effects of DEX using the specific inhibitors of PKC and MAPK. Rottlerin, an inhibitor of PKC, and SB202190, a p38 MAPK inhibitor, had no effects on the DEX inhibition of leptin-induced STAT3 activation (Fig. 5A) . In contrast, when 1 µM of PD98059, a MEK inhibitor, was added to the cells prior to treatment with DEX, the inhibitory effect of DEX on leptin-induced STAT3 phosphorylation was blocked. PD98059 by itself had no effects on the STAT3 phosphorylation (Fig. 5B) . We also determined whether PD98059 affects the inhibition of signaling events upstream of STAT3 phosphorylation.
We thus investigated the effect of PD98059 on leptin-induced JAK2 phosphorylation that is inhibited by DEX. Pretreatment of PD98059 prevented DEX-mediated inhibition of JAK2 phosphorylation. PD98059 itself did not alter the total amount of JAK2 protein or tyrosine phosphorylation of JAK2 (Fig. 5C ). Comparing these two concentrations, CSF:plasma ratio is around 10% after 6 h from DEX administration. This inhibitory effect of DEX was not observed in other cytokine receptors such as IL-6 and LIF receptor. We are unable to explain the difference between leptin and the IL-6 or LIF system with regard to the effects of DEX.
Although OBR is a member of the class I cytokine receptor family, it has been demonstrated that OBR transduces the signal via its homo-oligomerization without gp130, the signal transducing component for IL-6 and LIF receptor (39) . Furthermore, the structural analysis revealed that the extracellular domain of OBR contains two repeating cytokine receptor domain/fibronectin type 3 domains (CK-F3), in contrast to other members of the class I family (40) .
Hypersecretion of corticosterone has been observed in genetically obese rodents (41) and obese humans (42) . Continuous central administration of GCs to normal rats resulted in obesity associated with hyperleptinemia, in keeping with the increase in hypothalamic neuropeptide Y levels (32) . A central bolus injection of low dose leptin showed no significant effects in normal rats, but significantly decreased food intake and body weight in adrenalectomised rats (31) . In the present study, an icv 
